Pharma Journalist 9027 posts 0 comments

SMi reports: Deepen your understanding of crucial delivery methods and available platforms for non-hepatocytic delivery Join us at the Oligonucleotide Therapeutics and Delivery…
Read More...

SMi Reports: Hear from key industry players from San Francisco and the West Coast to learn about Device Innovations, Connected Delivery and Regulatory Guidance for Advanced Parenteral…
Read More...

SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore  new approaches using X ray Microscopy (XRM) from nano- to micro-scale  Webinar overview…
Read More...

BeiGene, Ltd. a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that the Center for Drug Evaluation (CDE) of the China…
Read More...

Bristol Myers Squibb announced that Opdivo(nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has granted Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), a first-in-class B-cell…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the launch of its MaxSignal Mycotoxin Automation Bundle. Using the new assays and automation…
Read More...

In draft guidance published today (19 August 2021), NICE has recommended midostaurin (Rydapt, Novartis) as a treatment for advanced systemic mastocytosis in adults. Mastocytosis is a…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New…
Read More...

Sorrento Therapeutics, Inc. a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical…
Read More...